Scientists develop new antibiotic molecule that kills several superbugs
- Fasting for 16 hours a day may increase the risk of cardiovascular death by 91%
- FDA Approves Groundbreaking Gene Therapy from UK’s Orchard Therapeutics
- Breakthrough in CAR-T therapy: Tumors almost completely disappear in just 5 days
- Adapalene can effectively activate senescence in prostate cancer cells and increase NK cell anti-tumor activity
- mRNA Therapy Unveils Hidden Cancer Cells: BioNTech’s IL-2 Breakthrough
- “Blood Test for Cancer”: Accuracy Up to 83% for Colorectal Cancer
Scientists develop new antibiotic molecule that kills several superbugs
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- Japan: Over 10,000 Applications for Health Damage from COVID-19 Vaccines
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- ‘Elixir of Immortality’ Nicotinamide Riboside (NR) Virtually No Effect
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Scientists develop new antibiotic molecule that kills several superbugs.
Bacteria are rapidly developing resistance to our best medicines, putting us on the brink of a major health crisis. But now, a new antibiotic has shown promise against several key “superbugs” while doing minimal damage to the good bacteria in the body.
Bacteria are a textbook example of evolutionary action. When they face environmental hazards, only the strongest bacteria survive to replicate, which means that eventually the entire population becomes resistant.
A class of bacteria called Gram-negative bacteria is particularly problematic, protecting themselves with thicker cell walls and molecular pumps that reject drugs.
The development of new antibiotics and other treatments has slowed. As a result, we humans are rapidly running out of effective antibiotics, threatening to return us to the “dark ages of medicine” — the days when even minor infections were fatal.
The scientists working on the new study have now developed a new candidate antibiotic that shows promise.
The team started with an existing antibiotic that was effective against Gram-positive bacteria and tried to make it more resistant to Gram-negative strains through a series of structural modifications.
One of the modified compounds was particularly striking. The drug candidate, named fabimycin, performed well against more than 200 clinically isolated groups of antibiotic-resistant bacteria, including a total of 54 strains such as Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii.
In tests on mice, fabimycin was found to clear drug-resistant cases of pneumonia or urinary tract infections and keep bacterial levels even below pre-infection levels.
Importantly, fabimycin is relatively selective in its attack and leaves certain types of harmless bacteria unaffected.
This is far better than many existing antibiotics, which indiscriminately wipe out many of the good bacteria in the microbiome leading to a host of unwanted side effects.
Further development could eventually add fabimycin or similar molecules to our arsenal against superbugs, especially those infections that are difficult to treat.
Scientists develop new antibiotic molecule that kills several superbugs
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.